Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Mireca |
Description | Protecting eyesight with a small molecule in a broad band of mutations Home About Science News Contact Protecting eyesight with a small molecule in a broa |
Keywords | N/A |
WebSite | mireca.eu |
Host IP | 198.185.159.144 |
Location | United States |
Site | Rank |
US$2,123
Last updated: 2023-05-07 08:19:27
mireca.eu has Semrush global rank of 0. mireca.eu has an estimated worth of US$ 2,123, based on its estimated Ads revenue. mireca.eu receives approximately 244 unique visitors each day. Its web server is located in United States, with IP address 198.185.159.144. According to SiteAdvisor, mireca.eu is safe to visit. |
Purchase/Sale Value | US$2,123 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$58 |
Yearly Ads Revenue | US$705 |
Daily Unique Visitors | 16 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
mireca.eu. | A | 900 | IP: 198.185.159.144 |
mireca.eu. | A | 900 | IP: 198.185.159.145 |
mireca.eu. | NS | 900 | NS Record: ns3.directictserver.info. |
mireca.eu. | NS | 900 | NS Record: ns2.directictserver.nl. |
mireca.eu. | NS | 900 | NS Record: ns1.directictserver.nl. |
mireca.eu. | MX | 900 | MX Record: 10 mireca-eu.mail.protection.outlook.com. |
mireca.eu. | TXT | 900 | TXT Record: v=spf1 include:spf.protection.outlook.com include:_spf.directictserver.nl ~all |
mireca.eu. | TXT | 900 | TXT Record: MS=ms92201441 |
Protecting eyesight with a small molecule in a broad band of mutations Home About Science News Contact Protecting eyesight with a small molecule in a broad band of mutations Home About Science News Contact MIRECA Corrected cGMP signaling Developing cGMP analogue drug products Mireca Medicines GmbH is an expanding, preclinical stage startup company pioneering the development of cyclic guanosine monophosphate (cGMP) analogues to treat diseases caused by a dysregulation of cGMP signaling, affecting protein kinase G (PKG). In a first selection to deploy its cGMP library for this pathway, Mireca focusses on the inhibition of cGMP signaling for neuroprotection. Positive preclinical data for inherited retinal diseases like Retinitis Pigmentosa and a licensing deal for all eye and ear applications with US Nasdaq listed Graybug Vision, Inc. confirms the drug development potential of this approach. In the light of Graybug’s merger with CalciMedica all assets were returned to Mireca for further |
HTTP/1.1 301 Moved Permanently Age: 248949 Date: Sun, 24 Oct 2021 19:08:11 GMT Location: https://www.mireca.eu/ Server: Squarespace Set-Cookie: crumb=BfymmlxMgKzJM2Q0NzhkZDdlNGYzZGYwZTRiNTU4MTExYmM5Zjll;Path=/ X-Contextid: FbCS2yMu/e4RnxBgg HTTP/2 200 accept-ranges: bytes age: 453189 content-type: text/html;charset=utf-8 date: Fri, 22 Oct 2021 10:24:12 GMT etag: W/"d1a15c9862f894c7b3a507b4690eebe9" expires: Thu, 01 Jan 1970 00:00:00 GMT server: Squarespace set-cookie: crumb=BW5cP4r/ZZ0YMjE2NzliZjA5NzMwOGQzOWM1M2Y0ODEyZTA1MWZh;Path=/ strict-transport-security: max-age=43200 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: ZbMtzu97/tvMH6BUt content-length: 10880 |
Domain: mireca.eu Script: LATIN NOT DISCLOSED! Visit www.eurid.eu for webbased WHOIS. NOT DISCLOSED! Visit www.eurid.eu for webbased WHOIS. Organisation: ISE Language: en Email: office@i-s-e.nl Name: Internet Service Europe BV Website: www.i-s-e.nl ns3.directictserver.info ns2.directictserver.nl ns1.directictserver.nl Please visit www.eurid.eu for more info. |